OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA Psychiatry is 75. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder	632
Suicide Mortality and Coronavirus Disease 2019—A Perfect Storm?	627
Establishment of Best Practices for Evidence for Prediction	414
Internet-Based Cognitive Behavioral Therapy for Depression	410
Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic	384
Addressing the COVID-19 Pandemic in Populations With Serious Mental Illness	341
Association Between Physical Activity and Risk of Depression	298
Perturbations in Gut Microbiota Composition in Psychiatric Disorders	291
Prevention of Psychosis	286
How COVID-19 Affects the Brain	285
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence	251
Association of Psychiatric Disorders With Mortality Among Patients With COVID-19	240
Battling the Modern Behavioral Epidemic of Loneliness	224
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder	219
Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia	214
From Basic Science to Clinical Application of Polygenic Risk Scores	192
Psychotherapy for Depression Across Different Age Groups: A Systematic Review and Meta-analysis	170
Mental Health in the Coronavirus Disease 2019 Emergency—The Italian Response	160
Could Polygenic Risk Scores Be Useful in Psychiatry?	160
Psychosocial Interventions and Immune System Function	156
Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death	154
Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries	152
Evaluation of Increases in Drug Overdose Mortality Rates in the US by Race and Ethnicity Before and During the COVID-19 Pandemic	152
Probability of Transition to Psychosis in Individuals at Clinical High Risk	151
Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms	151

Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder	151
Associations Between Prenatal Cannabis Exposure and Childhood Outcomes	150
Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post–COVID-19 Conditions	149
Posttraumatic Stress Disorder in Patients After Severe COVID-19 Infection	146
Telepsychiatry and the Coronavirus Disease 2019 Pandemic—Current and Future Outcomes of the Rapid Virtualization of Psychiatric Care	143
Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults	140
Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression	135
Association of OPRM1 Functional Coding Variant With Opioid Use Disorder	132
Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders	124
Immediate and Longer-Term Changes in the Mental Health and Well-being of Older Adults in England During the COVID-19 Pandemic	123
Dialectical Behavior Therapy for Posttraumatic Stress Disorder (DBT-PTSD) Compared With Cognitive Processing Therapy (CPT) in Complex Presentations of PTSD in Women Survivors of Childhood Abuse	122
Functional Magnetic Resonance Imaging–Guided Personalization of Transcranial Magnetic Stimulation Treatment for Depression	122
Cognitive Behavioral Treatments for Anxiety in Children With Autism Spectrum Disorder	119
The Coronavirus Disease 2019 (COVID-19) Outbreak and Mental Health	117
The Current Status of Psychedelics in Psychiatry	116
Association of Symptoms of Depression With Cardiovascular Disease and Mortality in Low-, Middle-, and High-Income Countries	116
Adjunctive Psychotherapy for Bipolar Disorder	115
Association of Suicide Prevention Interventions With Subsequent Suicide Attempts, Linkage to Follow-up Care, and Depression Symptoms for Acute Care Settings	114
Association of Outdoor Artificial Light at Night With Mental Disorders and Sleep Patterns Among US Adolescents	113
Psychosocial Stressors at Work and the Risk of Sickness Absence Due to a Diagnosed Mental Disorder	106
Effect of Layperson-Delivered, Empathy-Focused Program of Telephone Calls on Loneliness, Depression, and Anxiety Among Adults During the COVID-19 Pandemic	105
Effect of Zuranolone vs Placebo in Postpartum Depression	104
Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders	104
Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia	103
Efficacy of Digital Cognitive Behavioral Therapy for the Treatment of Insomnia Symptoms Among Pregnant Women	103
Transcriptomic Landscape and Functional Characterization of Induced Pluripotent Stem Cell–Derived Cerebral Organoids in Schizophrenia	102
Reward-Processing Behavior in Depressed Participants Relative to Healthy Volunteers	100
Coached Mobile App Platform for the Treatment of Depression and Anxiety Among Primary Care Patients	99
Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis	99
Association of High-Potency Cannabis Use With Mental Health and Substance Use in Adolescence	97
Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders	97
Male and Female Physician Suicidality	97
Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain	96
Racial Differences in Statewide Suicide Mortality Trends in Maryland During the Coronavirus Disease 2019 (COVID-19) Pandemic	95
Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure	94
Opportunities From the Coronavirus Disease 2019 Pandemic for Transforming Psychiatric Care With Telehealth	93
The Genetic Architecture of Depression in Individuals of East Asian Ancestry	91
Etiology of Autism Spectrum Disorders and Autistic Traits Over Time	90
Joint International Collaboration to Combat Mental Health Challenges During the Coronavirus Disease 2019 Pandemic	89
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses	87
National Trends in Mental Health Care for US Adolescents	86
Association of Preeclampsia in Term Births With Neurodevelopmental Disorders in Offspring	85
Association of Drug Cues and Craving With Drug Use and Relapse	84
Association of Cannabis Use During Adolescence With Neurodevelopment	84
Shared Genetic Loci Between Body Mass Index and Major Psychiatric Disorders	83
Sequential Combination of Pharmacotherapy and Psychotherapy in Major Depressive Disorder	80
All-Cause and Cause-Specific Mortality Among People Using Extramedical Opioids	80
Prevention of Incident and Recurrent Major Depression in Older Adults With Insomnia	79
Social Isolation and Loneliness in Older Adults—A Mental Health/Public Health Challenge	76
Methamphetamine Overdose Deaths in the US by Sex and Race and Ethnicity	76